Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005;32(3):437-9.

Octreotide for treating chylothorax after cardiac surgery

Affiliations
Case Reports

Octreotide for treating chylothorax after cardiac surgery

Dalokay Kilic et al. Tex Heart Inst J. 2005.

Abstract

Chylothorax is a rare but serious complication of cardiac surgery, with a poor prognosis unless treated properly. We report the case of 66-year-old woman who developed chylothorax after coronary artery bypass grafting. The chylothorax was successfully treated in 8 days by means of subcutaneous octreotide administration and a diet that contained medium-chain triglycerides. Octreotide, a long-acting somatostatin analog, is an effective and safe agent for the treatment of postoperative chylothorax and may reduce the need for reoperation.

PubMed Disclaimer

Figures

None
Fig. 1 Chest radiographs show A) pleural effusion and a mediastinal shift to the contralateral side and B) reexpansion of the lung 3 months after octreotide therapy.
None
Fig. 2 Graph shows daily chylous output during octreotide treatment.

Similar articles

Cited by

References

    1. Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Postoperative chylothorax. J Thorac Cardiovasc Surg 1996;112:1361–6. - PubMed
    1. Valentine VG, Raffin TA. The management of chylothorax. Chest 1992;102:586–91. - PubMed
    1. Allen EM, van Heeckeren DW, Spector ML, Blumer JL. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 1991; 26:1169–74. - PubMed
    1. Nakano A, Kato M, Watanabe T, Kawai N, Ota H, Hattori T, et al. OK-432 chemical pleurodesis for the treatment of persistent chylothorax. Hepatogastroenterology 1994;41: 568–70. - PubMed
    1. Nguyen DM, Shum-Tim D, Dobell AR, Tchervenkov CI. The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg 1995;10(4 Pt 1):302–8. - PubMed

Publication types